Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-23
1997-06-17
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514258, 514260, 514259, A61K 31505, A61K 3152
Patent
active
056397577
ABSTRACT:
Certain 4-aminopyrrolo[2,3-d]pyrimidine compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and are useful for immunoregulation and for the treatment of cancer, angiogenesis and atherosclerosis.
REFERENCES:
patent: 5036071 (1991-07-01), Johansson et al.
patent: 5457105 (1995-10-01), Barker
patent: 5475001 (1995-12-01), Barker
Chemical Abstracts 111:39290e, "Synthesis and Biological Activity of Pyrrolo [2,3-d] Pyrimidines", Dave et al. Aug. 1988.
Chaitanya, G. Dave. Indian Journal of Chemistry vol. 27B, Aug. 1988, pp. 778-780, "Synthesis & Biological Activity of Pyrrolo[2,3-d]pyrimidinest".
Chaitanya, G. Dave. Indian Journal of Chemistry 64, 713 (1987) pp. 713-715, "Pyrrolo[2,3-d]pyrimidines. Synthesis and Reaction of 2-Amino-3-cyanopyrroles".
Dow Robert L.
Koch Kevin
Benson Gregg C.
Krass Frederick
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
LandOfFree
4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157965